Relx PLC 6-K, filed Feb 13, 2025
Relx PLC (RELX)
About this 6-K
Relx PLC filed this 6-K on February 13, 2025.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
February 2025
Commission File Number: 001-13334
RELX PLC
(Translation of registrant’s name into English)
1-3 Strand
London
WC2N 5JR
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: ☒Form 20-F ☐ Form 40-F
EXHIBIT INDEX
Exhibit No | | Description |
| | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| RELX PLC | |
| | |
Date: 02/13/2025 | By: | /s/ A. Westley |
| Name: | A. Westley |
| Title: | Deputy Secretary |
| | |
13 February 2025
ISSUED ON BEHALF OF RELX PLC
Announcement of Non-Discretionary Share Buyback Programme
RELX PLC (the “Company”) announces in compliance with the UK and EU Market Abuse Regulations that it will implement an irrevocable, non-discretionary programme to repurchase its ordinary shares between 13 February 2025 and 23 April 2025 (the "Programme"), with a spend in this period of £450 million. This follows the successful completion of a £150 million non-discretionary programme on 7 February 2025. Both programmes are part of the £1.5 billion to be deployed on share buybacks in 2025, as announced on 13 February 2025.
The purpose of the Programme is to reduce the capital of the Company and it intends that shares purchased will be held in treasury.
Any share purchases will be made by the Company within certain pre-set parameters and in accordance with the general authority of the Company to repurchase shares granted by shareholders at the Company’s Annual General Meeting held on 25 April 2024 which, taking into account shares purchased subsequent to this meeting, permits the Company to purchase no more than 169.9 million ordinary shares. Any share purchases effected by the Company will be in accordance with the UK and EU Market Abuse Regulations and Chapter 12 of the Listing Rules.
The Company has entered into an agreement with UBS AG London Branch ("UBS") under which it has issued irrevocable instructions to UBS to manage the Programme. UBS will carry out the Company’s instructions through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. UBS will make its trading decisions under the Programme independently of, and uninfluenced by, the Company.
-ENDS-
Enquiries
Colin Tennant (Investors)
Tel : +44 (0)20 7166 5751
Paul Abrahams (Media)
Tel : +44 (0)20 7166 5724